Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors

Esophagogastric cancers have high recurrence rates with lymph nodes being a common pattern. Pre-treatment anemia has been
 reported an independent prognostic factor of treatment failure regardless of treatment strategy, particularly associated with poor
 locoregional control. A causa...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2009
Main Authors: Krzystek-Korpacka, M., Matusiewicz, M., Diakowska, D., Grabowski, K., Blachut, K., KustrzebaWojcicka, I., Gamian, A.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2009
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/134929
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors / M. Krzystek-Korpacka, M. Matusiewicz, D. Diakowska, K. Grabowski, K. Blachut, I. KustrzebaWojcicka, A. Gamian // Experimental Oncology. — 2009. — Т. 31, № 1. — С. 52-56. — Бібліогр.: 37 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862656922790920192
author Krzystek-Korpacka, M.
Matusiewicz, M.
Diakowska, D.
Grabowski, K.
Blachut, K.
KustrzebaWojcicka, I.
Gamian, A.
author_facet Krzystek-Korpacka, M.
Matusiewicz, M.
Diakowska, D.
Grabowski, K.
Blachut, K.
KustrzebaWojcicka, I.
Gamian, A.
citation_txt Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors / M. Krzystek-Korpacka, M. Matusiewicz, D. Diakowska, K. Grabowski, K. Blachut, I. KustrzebaWojcicka, A. Gamian // Experimental Oncology. — 2009. — Т. 31, № 1. — С. 52-56. — Бібліогр.: 37 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Esophagogastric cancers have high recurrence rates with lymph nodes being a common pattern. Pre-treatment anemia has been
 reported an independent prognostic factor of treatment failure regardless of treatment strategy, particularly associated with poor
 locoregional control. A causative relationship between anemia — tumor hypoxia — tumor aggressiveness mediated by angiogenesis
 up-regulation is advocated, yet remains controversial. Aim: To determine whether and how the pre-treatment anemia is associated
 with various aspects of disease aggressiveness and to evaluate the possible involvement of angiogenesis mediators. Methods:
 In 111 esophagogastric cancer patients we investigated the association of pre-treatment hemoglobin concentration and anemia
 presence with cancer-related, patients-related features and laboratory parameters including angiogenic factors: vascular endothelial
 growth factors A and C, interleukin-8 and midkine. Serum levels of angiogenic factors were assessed with immunoenzymatic tests.
 Results: Histology, disease stage, regional metastasis and dissemination in general, malnutrition and angiogenesis represented
 by midkine were found to correlate with anemia presence and hemoglobin concentration, while tumor extension, patient’s age and
 sex accounted only for anemia presence. A tendency towards hemoglobin correlation with VEGF-A and Il-8 was also observed.
 Midkine, tumor histology and malnutrition were found to exert an independent effect on pre-treatment hemoglobin concentration
 and anemia presence in esophagogastric cancer patients. Hemoglobin level of 12 g/dL was found an optimal cut-off value for discrimination
 between localized and disseminated cancers. Conclusions: Even a mild pre-treatment anemia is associated with cancers
 metastasizing especially to regional lymph nodes, which seems to be mediated by some of studied angiogenic factors.
first_indexed 2025-12-02T05:39:17Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-134929
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-12-02T05:39:17Z
publishDate 2009
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Krzystek-Korpacka, M.
Matusiewicz, M.
Diakowska, D.
Grabowski, K.
Blachut, K.
KustrzebaWojcicka, I.
Gamian, A.
2018-06-14T11:39:38Z
2018-06-14T11:39:38Z
2009
Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors / M. Krzystek-Korpacka, M. Matusiewicz, D. Diakowska, K. Grabowski, K. Blachut, I. KustrzebaWojcicka, A. Gamian // Experimental Oncology. — 2009. — Т. 31, № 1. — С. 52-56. — Бібліогр.: 37 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/134929
Esophagogastric cancers have high recurrence rates with lymph nodes being a common pattern. Pre-treatment anemia has been
 reported an independent prognostic factor of treatment failure regardless of treatment strategy, particularly associated with poor
 locoregional control. A causative relationship between anemia — tumor hypoxia — tumor aggressiveness mediated by angiogenesis
 up-regulation is advocated, yet remains controversial. Aim: To determine whether and how the pre-treatment anemia is associated
 with various aspects of disease aggressiveness and to evaluate the possible involvement of angiogenesis mediators. Methods:
 In 111 esophagogastric cancer patients we investigated the association of pre-treatment hemoglobin concentration and anemia
 presence with cancer-related, patients-related features and laboratory parameters including angiogenic factors: vascular endothelial
 growth factors A and C, interleukin-8 and midkine. Serum levels of angiogenic factors were assessed with immunoenzymatic tests.
 Results: Histology, disease stage, regional metastasis and dissemination in general, malnutrition and angiogenesis represented
 by midkine were found to correlate with anemia presence and hemoglobin concentration, while tumor extension, patient’s age and
 sex accounted only for anemia presence. A tendency towards hemoglobin correlation with VEGF-A and Il-8 was also observed.
 Midkine, tumor histology and malnutrition were found to exert an independent effect on pre-treatment hemoglobin concentration
 and anemia presence in esophagogastric cancer patients. Hemoglobin level of 12 g/dL was found an optimal cut-off value for discrimination
 between localized and disseminated cancers. Conclusions: Even a mild pre-treatment anemia is associated with cancers
 metastasizing especially to regional lymph nodes, which seems to be mediated by some of studied angiogenic factors.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
Article
published earlier
spellingShingle Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
Krzystek-Korpacka, M.
Matusiewicz, M.
Diakowska, D.
Grabowski, K.
Blachut, K.
KustrzebaWojcicka, I.
Gamian, A.
Original contributions
title Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
title_full Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
title_fullStr Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
title_full_unstemmed Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
title_short Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
title_sort even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
topic Original contributions
topic_facet Original contributions
url https://nasplib.isofts.kiev.ua/handle/123456789/134929
work_keys_str_mv AT krzystekkorpackam evenamildanemiaisrelatedtotumoraggressivenessmediatedbyangiogenicfactors
AT matusiewiczm evenamildanemiaisrelatedtotumoraggressivenessmediatedbyangiogenicfactors
AT diakowskad evenamildanemiaisrelatedtotumoraggressivenessmediatedbyangiogenicfactors
AT grabowskik evenamildanemiaisrelatedtotumoraggressivenessmediatedbyangiogenicfactors
AT blachutk evenamildanemiaisrelatedtotumoraggressivenessmediatedbyangiogenicfactors
AT kustrzebawojcickai evenamildanemiaisrelatedtotumoraggressivenessmediatedbyangiogenicfactors
AT gamiana evenamildanemiaisrelatedtotumoraggressivenessmediatedbyangiogenicfactors